Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects (2009)
- Authors:
- Autor USP: EVORA, PAULO ROBERTO BARBOSA - FMRP
- Unidade: FMRP
- Subjects: ÓXIDO NÍTRICO; ENDOTÉLIO; ARTÉRIA FEMORAL
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Medical Science Monitor
- ISSN: 1234-1010
- Volume/Número/Paginação/Ano: v. 15, n. 9, p. BR248-BR253, 2009
-
ABNT
CABLE, David George et al. Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects. Medical Science Monitor, v. 15, n. 9, p. BR248-BR253, 2009Tradução . . Acesso em: 05 maio 2024. -
APA
Cable, D. G., Celotto, A. C., Évora, P. R. B., & Schaff, H. V. (2009). Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects. Medical Science Monitor, 15( 9), BR248-BR253. -
NLM
Cable DG, Celotto AC, Évora PRB, Schaff HV. Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects. Medical Science Monitor. 2009 ; 15( 9): BR248-BR253.[citado 2024 maio 05 ] -
Vancouver
Cable DG, Celotto AC, Évora PRB, Schaff HV. Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects. Medical Science Monitor. 2009 ; 15( 9): BR248-BR253.[citado 2024 maio 05 ] - Budd-chiari syndrome in a 25-year-old woman with behçet's disease: a case report and review of the literature
- Endothelium dysfunction classification [Carta]: keeping the discussion opened
- Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta]
- Effect of the chronic metabollic acidosis on rat thoracic aorta reactivity
- Evolution of the Brazilian Journal of Cardiovascular Surgery [Editorial]
- Vasopressor support sparing strategies [Editorial]: a concept to be incorporated as a paradigm in the treatment of vasodilatory shock
- Presentation of an experimental method to induce in vitro ("organ chambers") respiratory acidosis and its effects on vascular reactivity
- Why methylene blue is the only option for blocking the cGMP/NO pathway in the treatment of vasoplegic shock? [Editorial]: "reasons that reason itself does not know…"
- Possible advances in vasopressors and inotropes support in shock. [Carta]
- Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
